Catalano Seafood Ltd
Catalano Seafood Ltd (CSF.AX) Stock Competitors & Peer Comparison
See (CSF.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CSF.AX | A$0.04 | N/A | 3.2M | -1.00 | -A$0.04 | N/A |
| A2M.AX | A$7.90 | -2.35% | 5.7B | 35.91 | A$0.22 | +0.83% |
| BKL.AX | A$94.73 | +0.03% | 1.8B | 53.82 | A$1.76 | N/A |
| BGA.AX | A$5.17 | -0.77% | 1.6B | 47.00 | A$0.11 | +1.93% |
| RIC.AX | A$2.89 | -0.69% | 1.1B | 24.08 | A$0.12 | +3.24% |
| CBO.AX | A$2.56 | -1.16% | 1.1B | 51.20 | A$0.05 | +1.29% |
| SHV.AX | A$3.39 | -1.45% | 481.7M | 14.74 | A$0.23 | N/A |
| SM1.AX | A$0.53 | -7.02% | 319.7M | -0.70 | -A$0.76 | N/A |
| BUB.AX | A$0.16 | +0.00% | 138.4M | -15.50 | -A$0.01 | N/A |
| BXN.AX | A$0.05 | -4.17% | 99.6M | -4.60 | -A$0.01 | N/A |
Stock Comparison
CSF.AX vs A2M.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, A2M.AX has a market cap of 5.7B. Regarding current trading prices, CSF.AX is priced at A$0.04, while A2M.AX trades at A$7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas A2M.AX's P/E ratio is 35.91. In terms of profitability, CSF.AX's ROE is -1.06%, compared to A2M.AX's ROE of +0.13%. Regarding short-term risk, CSF.AX is less volatile compared to A2M.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check A2M.AX's competition here
CSF.AX vs BKL.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, BKL.AX has a market cap of 1.8B. Regarding current trading prices, CSF.AX is priced at A$0.04, while BKL.AX trades at A$94.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas BKL.AX's P/E ratio is 53.82. In terms of profitability, CSF.AX's ROE is -1.06%, compared to BKL.AX's ROE of +0.08%. Regarding short-term risk, CSF.AX is less volatile compared to BKL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check BKL.AX's competition here
CSF.AX vs BGA.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, BGA.AX has a market cap of 1.6B. Regarding current trading prices, CSF.AX is priced at A$0.04, while BGA.AX trades at A$5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas BGA.AX's P/E ratio is 47.00. In terms of profitability, CSF.AX's ROE is -1.06%, compared to BGA.AX's ROE of +0.03%. Regarding short-term risk, CSF.AX is less volatile compared to BGA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check BGA.AX's competition here
CSF.AX vs RIC.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, RIC.AX has a market cap of 1.1B. Regarding current trading prices, CSF.AX is priced at A$0.04, while RIC.AX trades at A$2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas RIC.AX's P/E ratio is 24.08. In terms of profitability, CSF.AX's ROE is -1.06%, compared to RIC.AX's ROE of +0.12%. Regarding short-term risk, CSF.AX is less volatile compared to RIC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check RIC.AX's competition here
CSF.AX vs CBO.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, CBO.AX has a market cap of 1.1B. Regarding current trading prices, CSF.AX is priced at A$0.04, while CBO.AX trades at A$2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas CBO.AX's P/E ratio is 51.20. In terms of profitability, CSF.AX's ROE is -1.06%, compared to CBO.AX's ROE of +0.07%. Regarding short-term risk, CSF.AX is less volatile compared to CBO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check CBO.AX's competition here
CSF.AX vs SHV.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, SHV.AX has a market cap of 481.7M. Regarding current trading prices, CSF.AX is priced at A$0.04, while SHV.AX trades at A$3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas SHV.AX's P/E ratio is 14.74. In terms of profitability, CSF.AX's ROE is -1.06%, compared to SHV.AX's ROE of +0.00%. Regarding short-term risk, CSF.AX is less volatile compared to SHV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check SHV.AX's competition here
CSF.AX vs SM1.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, SM1.AX has a market cap of 319.7M. Regarding current trading prices, CSF.AX is priced at A$0.04, while SM1.AX trades at A$0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas SM1.AX's P/E ratio is -0.70. In terms of profitability, CSF.AX's ROE is -1.06%, compared to SM1.AX's ROE of -0.28%. Regarding short-term risk, CSF.AX is less volatile compared to SM1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check SM1.AX's competition here
CSF.AX vs BUB.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, BUB.AX has a market cap of 138.4M. Regarding current trading prices, CSF.AX is priced at A$0.04, while BUB.AX trades at A$0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas BUB.AX's P/E ratio is -15.50. In terms of profitability, CSF.AX's ROE is -1.06%, compared to BUB.AX's ROE of -0.26%. Regarding short-term risk, CSF.AX is less volatile compared to BUB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check BUB.AX's competition here
CSF.AX vs BXN.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, BXN.AX has a market cap of 99.6M. Regarding current trading prices, CSF.AX is priced at A$0.04, while BXN.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas BXN.AX's P/E ratio is -4.60. In terms of profitability, CSF.AX's ROE is -1.06%, compared to BXN.AX's ROE of +0.41%. Regarding short-term risk, CSF.AX is less volatile compared to BXN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check BXN.AX's competition here
CSF.AX vs CLV.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, CLV.AX has a market cap of 93.5M. Regarding current trading prices, CSF.AX is priced at A$0.04, while CLV.AX trades at A$0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas CLV.AX's P/E ratio is 18.67. In terms of profitability, CSF.AX's ROE is -1.06%, compared to CLV.AX's ROE of +0.07%. Regarding short-term risk, CSF.AX is less volatile compared to CLV.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check CLV.AX's competition here
CSF.AX vs HCT.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, HCT.AX has a market cap of 36.9M. Regarding current trading prices, CSF.AX is priced at A$0.04, while HCT.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas HCT.AX's P/E ratio is -5.50. In terms of profitability, CSF.AX's ROE is -1.06%, compared to HCT.AX's ROE of +0.04%. Regarding short-term risk, CSF.AX is less volatile compared to HCT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check HCT.AX's competition here
CSF.AX vs AHF.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, AHF.AX has a market cap of 33.4M. Regarding current trading prices, CSF.AX is priced at A$0.04, while AHF.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas AHF.AX's P/E ratio is -4.50. In terms of profitability, CSF.AX's ROE is -1.06%, compared to AHF.AX's ROE of -0.25%. Regarding short-term risk, CSF.AX is less volatile compared to AHF.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check AHF.AX's competition here
CSF.AX vs JAT.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, JAT.AX has a market cap of 32.1M. Regarding current trading prices, CSF.AX is priced at A$0.04, while JAT.AX trades at A$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas JAT.AX's P/E ratio is -38.50. In terms of profitability, CSF.AX's ROE is -1.06%, compared to JAT.AX's ROE of +0.04%. Regarding short-term risk, CSF.AX is less volatile compared to JAT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check JAT.AX's competition here
CSF.AX vs NOU.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, NOU.AX has a market cap of 31.9M. Regarding current trading prices, CSF.AX is priced at A$0.04, while NOU.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas NOU.AX's P/E ratio is -0.21. In terms of profitability, CSF.AX's ROE is -1.06%, compared to NOU.AX's ROE of +0.44%. Regarding short-term risk, CSF.AX is less volatile compared to NOU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check NOU.AX's competition here
CSF.AX vs NUC.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, NUC.AX has a market cap of 27.2M. Regarding current trading prices, CSF.AX is priced at A$0.04, while NUC.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas NUC.AX's P/E ratio is -2.92. In terms of profitability, CSF.AX's ROE is -1.06%, compared to NUC.AX's ROE of -0.53%. Regarding short-term risk, CSF.AX and NUC.AX have similar daily volatility (0.00).Check NUC.AX's competition here
CSF.AX vs FOD.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, FOD.AX has a market cap of 23.7M. Regarding current trading prices, CSF.AX is priced at A$0.04, while FOD.AX trades at A$0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas FOD.AX's P/E ratio is -10.00. In terms of profitability, CSF.AX's ROE is -1.06%, compared to FOD.AX's ROE of -0.22%. Regarding short-term risk, CSF.AX is less volatile compared to FOD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check FOD.AX's competition here
CSF.AX vs MBH.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, MBH.AX has a market cap of 22.7M. Regarding current trading prices, CSF.AX is priced at A$0.04, while MBH.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas MBH.AX's P/E ratio is -1.07. In terms of profitability, CSF.AX's ROE is -1.06%, compared to MBH.AX's ROE of -0.49%. Regarding short-term risk, CSF.AX is less volatile compared to MBH.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check MBH.AX's competition here
CSF.AX vs WNX.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, WNX.AX has a market cap of 16.9M. Regarding current trading prices, CSF.AX is priced at A$0.04, while WNX.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas WNX.AX's P/E ratio is -1.56. In terms of profitability, CSF.AX's ROE is -1.06%, compared to WNX.AX's ROE of -2.53%. Regarding short-term risk, CSF.AX is less volatile compared to WNX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check WNX.AX's competition here
CSF.AX vs CCO.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, CCO.AX has a market cap of 9M. Regarding current trading prices, CSF.AX is priced at A$0.04, while CCO.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas CCO.AX's P/E ratio is -0.30. In terms of profitability, CSF.AX's ROE is -1.06%, compared to CCO.AX's ROE of -5.41%. Regarding short-term risk, CSF.AX and CCO.AX have similar daily volatility (0.00).Check CCO.AX's competition here
CSF.AX vs EVE.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, EVE.AX has a market cap of 8.6M. Regarding current trading prices, CSF.AX is priced at A$0.04, while EVE.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas EVE.AX's P/E ratio is -3.50. In terms of profitability, CSF.AX's ROE is -1.06%, compared to EVE.AX's ROE of -2.14%. Regarding short-term risk, CSF.AX and EVE.AX have similar daily volatility (0.00).Check EVE.AX's competition here
CSF.AX vs BFC.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, BFC.AX has a market cap of 6M. Regarding current trading prices, CSF.AX is priced at A$0.04, while BFC.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas BFC.AX's P/E ratio is -0.10. In terms of profitability, CSF.AX's ROE is -1.06%, compared to BFC.AX's ROE of -1.11%. Regarding short-term risk, CSF.AX is less volatile compared to BFC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check BFC.AX's competition here
CSF.AX vs OJC.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, OJC.AX has a market cap of 5.3M. Regarding current trading prices, CSF.AX is priced at A$0.04, while OJC.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas OJC.AX's P/E ratio is -0.78. In terms of profitability, CSF.AX's ROE is -1.06%, compared to OJC.AX's ROE of -0.58%. Regarding short-term risk, CSF.AX is less volatile compared to OJC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check OJC.AX's competition here
CSF.AX vs HPP.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, HPP.AX has a market cap of 5.2M. Regarding current trading prices, CSF.AX is priced at A$0.04, while HPP.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas HPP.AX's P/E ratio is -0.84. In terms of profitability, CSF.AX's ROE is -1.06%, compared to HPP.AX's ROE of -0.02%. Regarding short-term risk, CSF.AX and HPP.AX have similar daily volatility (0.00).Check HPP.AX's competition here
CSF.AX vs FFF.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, FFF.AX has a market cap of 4.3M. Regarding current trading prices, CSF.AX is priced at A$0.04, while FFF.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas FFF.AX's P/E ratio is -0.60. In terms of profitability, CSF.AX's ROE is -1.06%, compared to FFF.AX's ROE of -0.89%. Regarding short-term risk, CSF.AX and FFF.AX have similar daily volatility (0.00).Check FFF.AX's competition here
CSF.AX vs NGS.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, NGS.AX has a market cap of 3.7M. Regarding current trading prices, CSF.AX is priced at A$0.04, while NGS.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas NGS.AX's P/E ratio is -0.35. In terms of profitability, CSF.AX's ROE is -1.06%, compared to NGS.AX's ROE of +2.43%. Regarding short-term risk, CSF.AX and NGS.AX have similar daily volatility (0.00).Check NGS.AX's competition here
CSF.AX vs PFT.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, PFT.AX has a market cap of 3.1M. Regarding current trading prices, CSF.AX is priced at A$0.04, while PFT.AX trades at A$0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas PFT.AX's P/E ratio is -0.73. In terms of profitability, CSF.AX's ROE is -1.06%, compared to PFT.AX's ROE of -0.47%. Regarding short-term risk, CSF.AX is less volatile compared to PFT.AX. This indicates potentially lower risk in terms of short-term price fluctuations for CSF.AX.Check PFT.AX's competition here
CSF.AX vs HLF.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, HLF.AX has a market cap of 2.8M. Regarding current trading prices, CSF.AX is priced at A$0.04, while HLF.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas HLF.AX's P/E ratio is -0.06. In terms of profitability, CSF.AX's ROE is -1.06%, compared to HLF.AX's ROE of -1.57%. Regarding short-term risk, CSF.AX and HLF.AX have similar daily volatility (0.00).Check HLF.AX's competition here
CSF.AX vs TFL.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, TFL.AX has a market cap of 2.2M. Regarding current trading prices, CSF.AX is priced at A$0.04, while TFL.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas TFL.AX's P/E ratio is -0.25. In terms of profitability, CSF.AX's ROE is -1.06%, compared to TFL.AX's ROE of -1.06%. Regarding short-term risk, CSF.AX and TFL.AX have similar daily volatility (0.00).Check TFL.AX's competition here
CSF.AX vs HVM.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, HVM.AX has a market cap of 2M. Regarding current trading prices, CSF.AX is priced at A$0.04, while HVM.AX trades at A$0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas HVM.AX's P/E ratio is -0.43. In terms of profitability, CSF.AX's ROE is -1.06%, compared to HVM.AX's ROE of -0.54%. Regarding short-term risk, CSF.AX and HVM.AX have similar daily volatility (0.00).Check HVM.AX's competition here
CSF.AX vs FIJ.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, FIJ.AX has a market cap of 1.2M. Regarding current trading prices, CSF.AX is priced at A$0.04, while FIJ.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas FIJ.AX's P/E ratio is -0.15. In terms of profitability, CSF.AX's ROE is -1.06%, compared to FIJ.AX's ROE of -2.13%. Regarding short-term risk, CSF.AX and FIJ.AX have similar daily volatility (0.00).Check FIJ.AX's competition here
CSF.AX vs MBX.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, MBX.AX has a market cap of 556.7K. Regarding current trading prices, CSF.AX is priced at A$0.04, while MBX.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas MBX.AX's P/E ratio is -0.07. In terms of profitability, CSF.AX's ROE is -1.06%, compared to MBX.AX's ROE of +19.24%. Regarding short-term risk, CSF.AX and MBX.AX have similar daily volatility (0.00).Check MBX.AX's competition here
CSF.AX vs NZS.AX Comparison August 2025
CSF.AX plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CSF.AX stands at 3.2M. In comparison, NZS.AX has a market cap of 333.4K. Regarding current trading prices, CSF.AX is priced at A$0.04, while NZS.AX trades at A$0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CSF.AX currently has a P/E ratio of -1.00, whereas NZS.AX's P/E ratio is -0.10. In terms of profitability, CSF.AX's ROE is -1.06%, compared to NZS.AX's ROE of -0.29%. Regarding short-term risk, CSF.AX and NZS.AX have similar daily volatility (0.00).Check NZS.AX's competition here